HWP
NUVB icon

Highline Wealth Partners’s Nuvation Bio NUVB Stock Holding History

Highline Wealth Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,000
Closed -$48.1K – 1137
2025
Q3 		$48.1K Hold
13,000
– – 0.01% 165
2025
Q2 		$25.4K Buy
+13,000
New +$27.1K 0.01% 195

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Highline Wealth Partners's NUVB Position: Q4 2025 in Review

Highline Wealth Partners sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 13,000 shares — an estimated $48.1K sold.

Highline Wealth Partners first reported a position in NUVB in Q2 2025 and held it in 2 quarters. The position peaked at $48.1K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Highline Wealth Partners reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Highline Wealth Partners sold 13,000 Nuvation Bio shares in Q4 2025, an estimated $48.1K.
  • Highline Wealth Partners first reported a position in Nuvation Bio in Q2 2025 and held it in 2 quarters.
  • Highline Wealth Partners's Nuvation Bio position peaked at $48.1K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Highline Wealth Partners's 13F filing for Q4 2025, filed 15 Jan 2026.